中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

13 records (took 0.018 seconds)

    Peripheral nerve field stimulation control
    2.
    发明授权
    Peripheral nerve field stimulation control 有权

    公开(公告)号：US10744326B2

    公开(公告)日：2020-08-18

    申请号：US14454427

    申请日：2014-08-07

    Applicant: Medtronic, Inc.

    Inventor： Gary W. King ,  Steven M. Goetz ,  Andrew H. Houchins ,  Jeffrey T. Keacher ,  Jordan J. Greenberg ,  Kenneth T. Heruth ,  Mark S. Lent ,  Paul W. Wacnik

    IPC: A61N1/36

    Abstract: Peripheral nerve field stimulation (PNFS) may be controlled based on detected physiological effects of the PNFS, which may be an efferent response to the PNFS. In some examples, a closed-loop therapy system may include a sensing module that senses a physiological parameter of the patient, which may be indicative of the patient's response to the PNFS. Based on a signal generated by the sensing module, the PNFS may be activated, deactivated or modified. Example physiological parameters of the patient include heart rate, respiratory rate, electrodermal activity, muscle activity, blood flow rate, sweat gland activity, pilomotor reflex, or thermal activity of the patient's body. In some examples, a patient pain state may be detected based on a signal generated by the sensing module, and therapy may be controlled based on the detection of the pain state.

    Peripheral nerve field stimulation control
    4.
    发明授权
    Peripheral nerve field stimulation control 有权

    公开(公告)号：US11752343B2

    公开(公告)日：2023-09-12

    申请号：US16985955

    申请日：2020-08-05

    Applicant: Medtronic, Inc.

    Inventor： Gary W. King ,  Steven M. Goetz ,  Andrew H. Houchins ,  Jeffrey T. Keacher ,  Jordan J. Greenberg ,  Kenneth T. Heruth ,  Mark S. Lent ,  Paul W. Wacnik

    IPC: A61N1/36

    CPC classification number: A61N1/36139 ,  A61N1/36057 ,  A61N1/36071

    Abstract: Peripheral nerve field stimulation (PNFS) may be controlled based on detected physiological effects of the PNFS, which may be an efferent response to the PNFS. In some examples, a closed-loop therapy system may include a sensing module that senses a physiological parameter of the patient, which may be indicative of the patient's response to the PNFS. Based on a signal generated by the sensing module, the PNFS may be activated, deactivated or modified. Example physiological parameters of the patient include heart rate, respiratory rate, electrodermal activity, muscle activity, blood flow rate, sweat gland activity, pilomotor reflex, or thermal activity of the patient's body. In some examples, a patient pain state may be detected based on a signal generated by the sensing module, and therapy may be controlled based on the detection of the pain state.

    INCONTINENCE THERAPY
    6.
    发明申请
    INCONTINENCE THERAPY 审中-公开

    公开(公告)号：US20160030741A1

    公开(公告)日：2016-02-04

    申请号：US14880066

    申请日：2015-10-09

    Applicant: Medtronic, Inc.

    Inventor： Xuan K. Wei ,  Eric H. Bonde ,  Keith A. Miesel ,  Mark S. Lent ,  Gregory F. Molnar

    IPC: A61N1/36 ,  A61N1/05

    CPC classification number: A61N1/36007 ,  A61N1/0514 ,  A61N1/0551 ,  A61N1/36128 ,  A61N1/36135 ,  A61N1/37235 ,  A61N1/37252

    Abstract: Techniques for managing urinary or fecal incontinence include delivering a first type of therapy to generate a first physiological response and, upon detecting a trigger event, delivering a second type of therapy to generate a second physiological response. The first type of therapy can be delivered on a substantially regular basis, while the second type of therapy is delivered as needed to provide an additional boost of therapy. The trigger event for activating the delivery of the second type of therapy may include input from a sensor that indicates a bladder condition, patient activity level or patient posture, or patient input. In some examples, the therapy is stimulation therapy.

    PERIPHERAL NERVE FIELD STIMULATION CONTROL
    8.
    发明公开
    PERIPHERAL NERVE FIELD STIMULATION CONTROL 审中-公开

    公开(公告)号：US20230381520A1

    公开(公告)日：2023-11-30

    申请号：US18231071

    申请日：2023-08-07

    Applicant: Medtronic, Inc.

    Inventor： Gary W. King ,  Steven M. Goetz ,  Andrew H. Houchins ,  Jeffrey T. Keacher ,  Jordan J. Greenberg ,  Kenneth T. Heruth ,  Mark S. Lent ,  Paul W. Wacnik

    IPC: A61N1/36

    CPC classification number: A61N1/36139 ,  A61N1/36071 ,  A61N1/36057

    Abstract: Peripheral nerve field stimulation (PNFS) may be controlled based on detected physiological effects of the PNFS, which may be an efferent response to the PNFS. In some examples, a closed-loop therapy system may include a sensing module that senses a physiological parameter of the patient, which may be indicative of the patient's response to the PNFS. Based on a signal generated by the sensing module, the PNFS may be activated, deactivated or modified. Example physiological parameters of the patient include heart rate, respiratory rate, electrodermal activity, muscle activity, blood flow rate, sweat gland activity, pilomotor reflex, or thermal activity of the patient's body. In some examples, a patient pain state may be detected based on a signal generated by the sensing module, and therapy may be controlled based on the detection of the pain state.

    PERIPHERAL NERVE FIELD STIMULATION CONTROL
    9.
    发明申请
    PERIPHERAL NERVE FIELD STIMULATION CONTROL 审中-公开

    公开(公告)号：US20200368532A1

    公开(公告)日：2020-11-26

    申请号：US16985955

    申请日：2020-08-05

    Applicant: Medtronic, Inc.

    Inventor： Gary W. King ,  Steven M. Goetz ,  Andrew H. Houchins ,  Jeffrey T. Keacher ,  Jordan J. Greenberg ,  Kenneth T. Heruth ,  Mark S. Lent ,  Paul W. Wacnik

    IPC: A61N1/36

    Abstract: Peripheral nerve field stimulation (PNFS) may be controlled based on detected physiological effects of the PNFS, which may be an efferent response to the PNFS. In some examples, a closed-loop therapy system may include a sensing module that senses a physiological parameter of the patient, which may be indicative of the patient's response to the PNFS. Based on a signal generated by the sensing module, the PNFS may be activated, deactivated or modified. Example physiological parameters of the patient include heart rate, respiratory rate, electrodermal activity, muscle activity, blood flow rate, sweat gland activity, pilomotor reflex, or thermal activity of the patient's body. In some examples, a patient pain state may be detected based on a signal generated by the sensing module, and therapy may be controlled based on the detection of the pain state.

    INCONTINENCE THERAPY
    10.
    发明申请
    INCONTINENCE THERAPY 有权
    不良治疗

    公开(公告)号：US20160367803A1

    公开(公告)日：2016-12-22

    申请号：US15256369

    申请日：2016-09-02

    Applicant: Medtronic, Inc.

    Inventor： Xuan K. Wei ,  Eric H. Bonde ,  Keith A. Miesel ,  Mark S. Lent ,  Gregory F. Molnar

    IPC: A61N1/36 ,  A61N1/372 ,  A61N1/05

    CPC classification number: A61N1/36007 ,  A61N1/0514 ,  A61N1/0551 ,  A61N1/36128 ,  A61N1/36135 ,  A61N1/37235 ,  A61N1/37252

    Abstract: Techniques for managing urinary or fecal incontinence include delivering a first type of therapy to generate a first physiological response and, upon detecting a trigger event, delivering a second type of therapy to generate a second physiological response. The first type of therapy can be delivered on a substantially regular basis, while the second type of therapy is delivered as needed to provide an additional boost of therapy. The trigger event for activating the delivery of the second type of therapy may include input from a sensor that indicates a bladder condition, patient activity level or patient posture, or patient input. In some examples, the therapy is stimulation therapy.

    Abstract translation: 用于管理尿失禁或大便失禁的技术包括递送第一类型的治疗以产生第一生理反应，并且在检测到触发事件时，递送第二类型的治疗以产生第二生理反应。 第一种类型的治疗可以基本上定期地递送，而第二种类型的治疗根据需要被递送以提供额外的治疗效果。 用于激活第二类治疗的递送的触发事件可以包括来自传感器的输入，其指示膀胱状况，患者活动水平或患者姿势或患者输入。 在一些例子中，治疗是刺激疗法。

Patent Agency Ranking